Literature DB >> 27480097

The value of hypercalciuria in patients with osteopenia versus osteoporosis.

María Sierra Girón-Prieto1, María Del Carmen Cano-García2, Antonio Poyatos-Andújar3, Salvador Arias-Santiago4, Tomás de Haro-Muñoz5, Miguel Arrabal-Martín6, Miguel Ángel Arrabal-Polo7.   

Abstract

The aim of this study was to analyze the presence of lithogenic metabolic factors in the blood and urine of patients with osteopenia versus osteoporosis. This is a cross-sectional study including 67 patients who were divided into two groups according to the presence of either osteopenia or osteoporosis as measured by bone densitometry: group 1-40 patients with osteopenia (22 men and 18 women) and group 2-27 patients with osteoporosis (13 men and 14 women). Metabolic studies were performed on the blood and urine; statistical analysis was performed comparing means and conducting linear correlation and multivariate analyses with SPSS. Statistical significance was considered to be p ≤ 0.05. The mean age of patients in group 1 was 52.9 ± 12.8 years versus 50.3 ± 11.4 in group 2; the difference was not statistically significant. In group 2, higher levels of osteocalcin, β-crosslaps, urinary calcium, fasting urine calcium/creatinine, 24 h urine calcium/creatinine and 24 h oxaluria were observed compared to group 1. In the multivariate analysis, only the β-crosslaps and urinary calcium were independently associated with osteoporosis. It would be advisable to determine the urinary calcium levels in patients with osteoporosis since altered levels may necessitate modifying the diagnostic and therapeutic approach to osteoporosis.

Entities:  

Keywords:  Bone markers; Calciuria; Osteopenia; Osteoporosis

Mesh:

Substances:

Year:  2016        PMID: 27480097     DOI: 10.1007/s00240-016-0909-2

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  19 in total

Review 1.  Idiopathic hypercalciuria and bone health.

Authors:  Laura E Ryan; Steven W Ing
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

Review 2.  Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management.

Authors:  Miguel A Arrabal-Polo; María del Carmen Cano-García; Benjamin K Canales; Miguel Arrabal-Martín
Journal:  Curr Opin Urol       Date:  2014-11       Impact factor: 2.309

Review 3.  Hypercalciuria.

Authors:  M Audran; E Legrand
Journal:  Joint Bone Spine       Date:  2000       Impact factor: 4.929

Review 4.  Secondary osteoporosis: a review of the recent evidence.

Authors:  Stephanie E Painter; Michael Kleerekoper; Pauline M Camacho
Journal:  Endocr Pract       Date:  2006 Jul-Aug       Impact factor: 3.443

5.  Osteoporosis in men: the value of laboratory testing.

Authors:  C S Ryan; V I Petkov; R A Adler
Journal:  Osteoporos Int       Date:  2010-10-09       Impact factor: 4.507

Review 6.  Osteoporosis in men.

Authors:  Evelien Gielen; Dirk Vanderschueren; Filip Callewaert; Steven Boonen
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2011-04       Impact factor: 4.690

7.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

Review 8.  Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment.

Authors:  Wojciech P Olszynski; K Shawn Davison; Jonathan D Adachi; Jacques P Brown; Steven R Cummings; David A Hanley; Steven P Harris; Anthony B Hodsman; David Kendler; Michael R McClung; Paul D Miller; Chui Kin Yuen
Journal:  Clin Ther       Date:  2004-01       Impact factor: 3.393

9.  Evaluation of secondary causes that may lead to bone loss in women with osteoporosis: a retrospective study.

Authors:  Ersin Odabasi; Mustafa Turan; Faruk Tekbas; Mustafa Kutlu
Journal:  Arch Gynecol Obstet       Date:  2008-11-20       Impact factor: 2.344

Review 10.  Secondary causes of osteoporosis.

Authors:  Susan M Delange Hudec; Pauline M Camacho
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

View more
  1 in total

Review 1.  Screening Tools for Osteoporosis in India: Where Do We Place Them in Current Clinical Care?

Authors:  Kripa Elizabeth Cherian; Nitin Kapoor; Meeta Meeta; Thomas Vizhalil Paul
Journal:  J Midlife Health       Date:  2022-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.